These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2146019)

  • 21. Nicorandil-induced changes in the distribution of cardiac output and coronary blood flow in pigs.
    Verdouw PD; Sassen LM; Duncker DJ; Schmeets IO; Rensen RJ; Saxena PR
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Sep; 336(3):352-8. PubMed ID: 2960904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Successful treatment of intraoperative myocardial ischemia with nicorandil].
    Kawamura S; Hayashida M; Orii R; Sawamura S; Komatsu K; Ito N; Kuzumi E; Hanaoka K
    Masui; 1997 Apr; 46(4):531-7. PubMed ID: 9128027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nicorandil attenuates myocardial dysfunction associated with transient ischemia by opening ATP-dependent potassium channels.
    Auchampach JA; Cavero I; Gross GJ
    J Cardiovasc Pharmacol; 1992; 20(5):765-71. PubMed ID: 1280739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the new nitrate ester ITF 296 on coronary and systemic hemodynamics in the conscious dog: comparison with nitroglycerin and nicorandil.
    Ueno A; Bergamaschi M; Gromo G; Nonaka K; Mizrahi J
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S13-20. PubMed ID: 8839221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nicorandil releases acetylcholine-induced sustained coronary arterial constriction in monkeys and baboons.
    Satoh K; Maruyama M; Yamashita S; Taira N
    Jpn Heart J; 1984 Mar; 25(2):267-73. PubMed ID: 6235383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salutary effect of adjunctive intracoronary nicorandil administration on restoration of myocardial blood flow and functional improvement in patients with acute myocardial infarction.
    Sakata Y; Kodama K; Komamura K; Lim YJ; Ishikura F; Hirayama A; Kitakaze M; Masuyama T; Hori M
    Am Heart J; 1997 Jun; 133(6):616-21. PubMed ID: 9200388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of nicorandil on coronary collateral circulation depend on the donor arteries].
    Umezawa S; Ogawara S; Okamoto Y; Igawa M; Aonuma K; Inada M; Korenaga M; Hiroe M; Marumo F
    J Cardiol; 1996 Nov; 28(5):257-66. PubMed ID: 8953399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimation of coronary flow reserve by intracoronary administration of nicorandil: comparison with intracoronary administration of papaverine.
    Inoue F; Hashimoto T; Fujimoto S; Uemura S; Kawamoto A; Dohi K
    Heart Vessels; 1998; 13(5):229-36. PubMed ID: 10483772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recovery of contractile function in post-ischaemic reperfused myocardium of conscious dogs: influence of nicorandil, a new antianginal agent.
    Shimshak TM; Preuss KC; Gross GJ; Brooks HL; Warltier DC
    Cardiovasc Res; 1986 Aug; 20(8):621-6. PubMed ID: 2947685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nicorandil and cardiovascular performance in patients with coronary artery disease.
    Suryapranata H; MacLeod D
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S45-51. PubMed ID: 1282175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitrate tolerance: comparison of nicorandil, isosorbide dinitrate, and nitroglycerin in anesthetized dogs.
    Sakai K; Kuromaru O
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S17-24. PubMed ID: 2447420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The central and regional cardiovascular responses to intravenous and intracoronary administration of the phenyldihydropyridine elgodipine in anaesthetized pigs.
    Sassen LM; Soei LK; Koning MM; Verdouw PD
    Br J Pharmacol; 1990 Feb; 99(2):355-63. PubMed ID: 2328400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Examination of the direct effects of antianginal agents on the hypoxic canine myocardium.
    Nakamura Y; Kojima S; Mori H; Nagata M; Miyazaki T; Miyamori R; Hattori S; Takahashi M
    Jpn Heart J; 1987 Sep; 28(5):737-46. PubMed ID: 2963155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An ATP-sensitive potassium (KATP) channel opener, nicorandil, lowers the threshold for ischemic preconditioning in barbital-anesthetized dogs.
    Mizumura T; Saito S; Ozawa Y; Kanmatsuse K; Gross GJ
    Heart Vessels; 1997; Suppl 12():175-7. PubMed ID: 9476575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of no-reflow/slow-flow phenomenon during rotational atherectomy--a prospective randomized study comparing intracoronary continuous infusion of verapamil and nicorandil.
    Matsuo H; Watanabe S; Watanabe T; Warita S; Kojima T; Hirose T; Iwama M; Ono K; Takahashi H; Segawa T; Minatoguchi S; Fujiwara H
    Am Heart J; 2007 Nov; 154(5):994.e1-6. PubMed ID: 17967610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracoronary propofol does not decrease myocardial contractile function in the dog.
    Belo SE; Kolesar R; Mazer CD
    Can J Anaesth; 1994 Jan; 41(1):43-9. PubMed ID: 8111942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. K+ channel-opening action contributes to the preventive effects of nicorandil on U46619-induced vasoconstriction of canine large coronary arteries in vivo.
    Kamijo T; Iwai T; Haruta K; Takeda K
    Arch Int Pharmacodyn Ther; 1996; 331(3):273-84. PubMed ID: 9124999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of endothelin-induced malignant ventricular arrhythmias in dogs.
    Merkely B; Gellér L; Tóth M; Kiss O; Kékesi V; Solti F; Vecsey T; Horkay F; Tenczer J; Juhász-Nagy A
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S437-9. PubMed ID: 9595506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nicorandil attenuates myocardial acidosis during coronary occlusion in dogs.
    Abiko Y; Nishimura T; Sakai K
    Br J Pharmacol; 1984 Feb; 81(2):409-11. PubMed ID: 6231074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dilator effects of nicorandil on isolated perfused coronary arteries of humans.
    Sakaino N; Araki H; Nishi K
    Arch Int Pharmacodyn Ther; 1990; 306():100-5. PubMed ID: 2150166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.